Mercer Global Advisors
TLX

Mercer Global Advisors’s Telix Pharmaceuticals TLX Stock Holding History

Mercer Global Advisors’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+1,088
New +$11.1K ﹤0.01% 5036

Other funds holding TLX

PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $20.5B AUM 24.45% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Mercer Global Advisors's TLX Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Telix Pharmaceuticals (TLX) in Q2 2026: 1,088 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #5036 among its holdings.

40 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • Mercer Global Advisors held 1,088 shares of Telix Pharmaceuticals worth $12.5K as of Q2 2026.
  • Telix Pharmaceuticals was a new Mercer Global Advisors position in Q2 2026.
  • Telix Pharmaceuticals made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5036 holding.
  • 40 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.